The New Virtual Meeting Experience: What to See at IAS

Each year, the Interdisciplinary Autoimmune Summit (IAS) brings together providers from various specialties, such as dermatology, gastroenterology, and rheumatology, to discuss and learn about the latest in the treatment and management of immune-mediated inflammatory diseases (IMIDs). While the current coronavirus disease 2019 (COVID-19) pandemic has resulted in the cancellation of many live events, this year’s virtual meeting will still connect health care practitioners across various fields and offer attendees up to 22.5 CME/CNE/CPE credits.

“Although the meeting may be virtual, the information, updates, guidances and pathways, along with interactive discussions with faculty, will be real-life, timely, and integrated between our immune-mediated disease colleagues,” said Stephen B. Hanauer, MD, FACG, senior advisor of IAS and medical director of the Digestive Health Center at Northwestern University Feinberg School of Medicine in Chicago, IL.

From July 10 through July 12, 2020, attendees can watch live sessions, engage with faculty in live Q&As, and view additional on-demand sessions from the comfort of their own home. All live sessions will also be available on-demand within 24 hours of the live presentation. In addition, attendees can participate in “Interact at IAS” for a chance to win prizes by engaging with sponsors and exhibitors in the virtual exhibit hall. Registered attendees will receive a link with information on how to access the meeting materials. For questions, please contact registration.

Live sessions at the meeting will include:

• The Expanding Role of JAK Inhibitors across IMIDs presented by Vibeke Strand, MD, MACR, FACP
• Roundtable: Impact of COVID-19 on Autoimmune Diseases presented by Cassandra Calabrese, DO; Leonard Calabrese, DO; Joel M. Gelfand, MD, MSCE; and Stephen B. Hanauer, MD, FACG
• Using Personal Technology to Improve and Track Outcomes in Inflammatory Arthritis presented by Alexis Ogdie
• Psoriatic Disease in the Telehealth Era presented by Joseph F. Merola, MD, MMSc; and Alice B Gottlieb, MD, PhD
• Emerging Cell Therapeutics for Use in Autoimmune Diseases presented by Biju Parekkadan, PhD

On-Demand sessions include:

• Bioelectronic Medicine for Treatment of Rheumatoid Arthritis presented by David Chernoff, MD
• Choosing Initial Treatment in New-Onset IBD presented by Adam S. Cheifetz, MD
• Pulmonary Manifestations of Rheumatic Disease presented by Jeffrey A. Sparks, MD, MMSc
• Dermatologic Complications of Inflammatory Bowel Disease and Approach to Management presented by Bridget Shields, MD
• New Therapeutic Advances in Atopic Dermatitis presented by Emma Guttman, MD, PhD

Dates, times, and other live and on-demand sessions are available here.

“The IAS platform is crucial to our ability to share lessons learned through this health crisis across disciplines caring for our immune-mediated diseases,” said Joseph Merola, MD, MMSc, co-chair of IAS and vice chair of Clinical Trials and Innovation at Brigham and Women's Hospital in Boston, MA. More information is available at the IAS meeting website.

Registration for the meeting is open through July 9, 2020.